Point-of-care hemoglobin A1c margin of error alters resident management of Type 2 diabetes when near glycemic target

Point-of-care (POC) HbA1c is frequently used as a surrogate for serum HbA1c. We aimed to determine if resident management of type 2 diabetes changed after accounting for the +  0.5% margin of error associated with POC HbA1c devices.
Source: Primary Care Diabetes - Category: Primary Care Authors: Source Type: research